lymphoma
Advertisement
First-line treatment with the autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy axicabtagene ...
According to results from the phase III BELINDA trial, patients with relapsed/refractory aggressive B-cell non-Hodgkin ...
Zanubrutinib Plus Venetoclax Well-Tolerated, Effective as First-Line Therapy for CLL/SLL With Del17p
Preliminary data from a nonrandomized arm of the SEQUOIA trial, presented at the 2021 Annual Meeting of the American ...
Each week on DocWire News, editors bring you the latest in oncology news and cancer research. In case you missed it, ...
Did you know September is Blood Cancer Awareness Month? This month, take the time to learn more about this disease, ...
A study of patients aged ≥60 years with lymphoma found that a high-dose chemotherapy regimen followed by autologous ...
The effect of graft-versus-host lymphoma (GVL) is correlated with graft-versus-host disease (GVHD), according to a study ...
When physicians suspect a diagnosis of certain conditions, a referral to a hematologist is warranted.
Postoperative Cancer Mortality Is Declining, But Racial Disparities Are Not Changing
...
A fixed-duration venetoclax (Ven)-based regimen is considered a standard of care (SOC) option for patients with ...
The introduction of novel agents has given patients with chronic lymphocytic leukemia (CLL) and small lymphocytic ...
ASH 2020: ZUMA-12 Study Assesses CAR T-Cell Therapy as Frontline Treatment for Large B-Cell Lymphoma
Sattva S. Neelapu, MD, of the University of Texas MD Anderson Cancer Center in Houston, TX, discusses outcomes from the ...
Zanubrutinib has been shown to be an effective treatment in patients with chronic lymphocytic leukemia (CLL)/small ...
Certain genomic abnormalities are predictive of poor outcomes in chemoimmunotherapy (CIT) in patients with chronic ...
Researchers from the University of Alberta have identified a new mechanism of cell signal inhibition that could prove ...
Actor Jeff Bridges Reveals Lymphoma Diagnosis
...
Jeff Bridges has been diagnosed with lymphoma, the actor announced on Twitter Monday evening.
...
A study published in Blood found that tandem chimeric antigen receptor (CAR) T-cells showed dual antigen targeting of ...
Anti-CD19 chimeric antigen receptor (CAR) T-cells cause remission of relapsed B-cell lymphoma and chronic lymphocytic ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.